✦ LIBER ✦

Ciprofloxacin pharmacokinetics in patients with cystic fibrosis

✍ Scribed by S. W. Bender; H. G. Posselt; A. Dalhoff; P. M. Shah; R. Strehl

Publisher: Springer-Verlag
Year: 1986
Tongue: English
Weight: 567 KB
Volume: 14
Category: Article
ISSN: 0300-8126
DOI: 10.1007/bf01644804

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Utilization of salivary concentrations o

Utilization of salivary concentrations of ciprofloxacin in subjects with cystic fibrosis

✍ A. Smith; A. Weber; Rimmie Pandher; Judy Williams-Warren; M. L. Cohen; B. Ramsey 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 522 KB

Antimicrobial chemotherapy in patients w

Antimicrobial chemotherapy in patients with cystic fibrosis

✍ J. P. Guggenbichler; J. Schneeberger 📂 Article 📅 1987 🏛 Springer-Verlag 🌐 English ⚖ 807 KB

Myocardial fibrosis — a rare complicatio

Myocardial fibrosis — a rare complication in patients with cystic fibrosis

✍ W. Wiebicke; A. Artlich; I. Gerling 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 634 KB

Cyclosporin pharmacokinetics in heart-lu

Cyclosporin pharmacokinetics in heart-lung transplant recipients with cystic fibrosis

✍ V. T. Tsang; A. Johnston; F. Heritier; N. Leaver; M. E. Hodson; M. Yacoub 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 529 KB

Cyclosporin (CsA) is currently the main immunosuppressive agent used in organ transplantation with considerable improvement in graft survival. Oral CsA solution is highly lipophilic, and its bioavailability may be reduced in cystic fibrosis (CF) heart-lung transplant recipients with pancreatic, gas

Quality of life in patients with cystic

Quality of life in patients with cystic fibrosis

✍ Wietze de Jong; Adrian A. Kaptein; Cees P. van der Schans; Gregor P. M. Mannes; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 2 views

The majority of patients with cystic fibrosis (CF) will grow into adulthood. Despite this improvement in survival, the disease is progressive, especially with respect to the decline in pulmonary function, which in turn may have an impact on a patient's quality of life. In this study we evaluated the

Dopamine-beta-hydroxylase in patients wi

Dopamine-beta-hydroxylase in patients with cystic fibrosis

✍ M. H. Schöni; K. Türler; H. Käser; R. Kraemer 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 456 KB

The enzymatic activity of plasma dopamine-betahydroxylase (DBH) was determined in 92 children/adolescents with cystic fibrosis, in 25 parents (heterozygotes) of these patients and in 68 healthy controls. Statistically significant (P<0.01) lower DBH levels were found in cystic fibrosis patients (17.9